SAMANTHA SUDANO: Open Payments
NPI 1598534976 · SUPPLY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 48 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $592 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 4 | $62 |
| Alkermes, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, FANAPT, INGREZZA, ARISTADA, REXULTI, Auvelity, ABILIFY MAINTENA.
Industry payments across NC — which companies pay providers there.
